Increase Your Exposure Through Trade Journals
Trade Journals are the magazines which discuss topics related to their field of business. It is important to have a strong presence in trade journals of the same niche as your business. Trade Journals help you get your name out there, position you as an expert and increase customer traffic.
For instance, if you run a veterinary clinic, it’s important for potential pet owners to see that you are active in this industry. You could publish articles about how having pets makes people healthier or how caring for your pet is no different from caring for a child or other relative. These articles will make readers feel like they can connect with you and will increase your credibility.
It is important to get your name out there in this way. If you are an expert, people will trust in you and prefer to do business with you. You’ll also be able to get great testimonials about your business that you can include in your marketing materials.
When it comes down to it, trade journals are a great way to make money and gain exposure for your business or organization. If you’re interested in trying out trade journal publishing, check out MBS Business Media Inc. They specialize in helping small businesses follow through on their marketing goals.
Another great site for trade journal publishing is Profit.com. They offer writers access to all of their tools, including templates for each trade journal, which have been chosen by the staff who work at Profit Magazine. Profit Magazine is one of the largest business and finance magazines around today. You can also access this magazine and others through Profit.com’s site.
Do you want to know more about Trade Journals? Visit our website at www.profit.com to learn more about Trade Journals and how they can help your business succeed! Profit Magazine publishes articles that have been written by experts in the field, providing you with the best articles available on trade journals and other relevant topics for small businesses.
Check out Profit Magazine on Twitter @ProfitMag and Facebook at http://www.facebook.com/profitmagazine .
You can also get more information about publishing in trade journals from our site.
If you want to submit articles for Profit Magazine or any of the other great trade magazines we publish, click here for more information!
* http://www.profit.com/trade-journals/ * http://www.profitmagazine.com/article/increase-your-exposure-through-trade-journals/ * Increase Your Exposure Through Trade Journals * __________ * http://www.profitmagazine.com/article/increase-your-exposure-through-trade-journals/ - 13608 * __________ * http://www.profitmagazine.com/article/increase-your-exposure-through-trade-journals/ - 18164 * __________ * Increase Your Exposure Through Trade Journals *
For more information visit our website at: http://www.profit.com or get a free subscription to Profit Magazine at http://www.profitmagazine.com and get the word out about your business!
Our Trade Journal Marketing Services have been helping small businesses since 1999 to reach their customers, create buzz, and build their brand. Advertise your business on Profit Magazine at http://www.profitmagazine.com !
Summary:
The simple introduction of a local doctor in the trade journal The New England Journal of Medicine in 1964 helped to launch a revolution in medical practice and research. Writing under the pen name of Dr. Leonard Borland, the physician praised some common cold remedies, including aspirin, and called for more studies on their efficacy (aspirin has since been proven highly effective against colds).
This "open letter to the profession," as it was called, was reprinted in Reader's Digest, discovered by television talk show hosts, and ultimately led to more than 70 percent of Americans regularly taking aspirin. It also helped give a huge boost to the field of medical advertising.
The New England Journal of Medicine had been accepting advertising from drug companies for almost half a century when Borland's letter appeared. The first ad appeared back in 1879, when a French firm sold a digestive aid for babies that the company claimed would prevent food allergies later in life. The journal's editor at the time accepted the ad because he feared competitors would run it if he did not—with or without his permission. (See also: "How to Launch a Revolution in Medical Practice, Part 2.")
Nonprofit journals and magazines operated by universities and foundations also accepted ads. As journals devoted more space to covering new discoveries, their editors believed the ads would help support the publication. Drug companies were among the first to realize that a few pages of advertising in a scientific journal could be a powerful marketing tool. An early entrant was Parke, Davis & Co., which launched a magazine for pharmacists in 1891 because large numbers of physicians read pharmaceutical journals.
Particularly during the 1900s and 1910s, major drug companies pursued a strategy of buying up small regional or specialty journals that were devoted to a therapy or medical problem. They were already well-known for their research into heart medicines and drugs for high blood pressure. They could then quickly disseminate new information. By the mid-1920s, Merck & Co., Pfizer & Co., Eli Lilly & Co., and other firms had bought up scores of journals—including The New England Journal of Medicine. The pharmaceutical industry soon realized that "discovery" was the key to marketing drugs, so they began funding the scientific research that led to these discoveries.
Conclusion:
The pharmaceutical industry's use of medical journals grew rapidly. "By the early 1920s, for example, Merck & Co. alone was publishing about twenty different periodicals in an effort to exploit its research and findings," writes John K. Jenkins in his book Selling Medicines: A History of the Pharmaceutical Industry. "Within a decade, the industry as a whole had greatly expanded this practice." By 1936, when President Franklin Delano Roosevelt began his term in office, it was clear that industry-supported journals were far more often reporting favorable findings on drugs than those that did not have financial ties to the companies.